Moreover, the ADRB2 could reduce atheroscleroticplaque cellularity through reducing vascular smooth muscle cell proliferation, animportant feature of atherosclerotic lesion formation, leading to instability andrupture of the plaques and increasing the risk of MI and CAD (Piscione et al., 2008). The gene discussed is ADRB2; the disease is coronary artery disorder.